Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRBP |
---|---|---|
09:32 ET | 4517 | 18.5501 |
09:33 ET | 1577 | 19 |
09:35 ET | 500 | 18.98 |
09:37 ET | 4845 | 18.87 |
09:39 ET | 400 | 18.985 |
09:42 ET | 2618 | 19.0899 |
09:44 ET | 300 | 19 |
09:46 ET | 700 | 18.85 |
09:48 ET | 258 | 18.8 |
09:50 ET | 100 | 18.82 |
09:51 ET | 514 | 18.7101 |
09:53 ET | 130 | 18.72 |
09:55 ET | 216 | 18.72 |
09:57 ET | 2800 | 18.88 |
10:00 ET | 1200 | 18.8 |
10:02 ET | 400 | 18.755 |
10:04 ET | 1385 | 18.725 |
10:06 ET | 1100 | 18.7305 |
10:08 ET | 500 | 18.6835 |
10:09 ET | 2708 | 18.625 |
10:11 ET | 400 | 18.69 |
10:13 ET | 300 | 18.75 |
10:15 ET | 200 | 18.7575 |
10:18 ET | 2316 | 18.87 |
10:20 ET | 300 | 18.83 |
10:22 ET | 847 | 18.83 |
10:24 ET | 100 | 18.835 |
10:26 ET | 764 | 18.78 |
10:27 ET | 300 | 18.725 |
10:29 ET | 500 | 18.7196 |
10:33 ET | 1386 | 18.6672 |
10:36 ET | 500 | 18.82 |
10:38 ET | 200 | 18.815 |
10:40 ET | 400 | 18.79 |
10:42 ET | 110 | 18.77 |
10:44 ET | 1500 | 18.71 |
10:45 ET | 100 | 18.6307 |
10:47 ET | 410 | 18.6368 |
10:49 ET | 100 | 18.63 |
10:51 ET | 100 | 18.69 |
10:54 ET | 100 | 18.63 |
10:56 ET | 6301 | 18.535 |
11:05 ET | 600 | 18.62 |
11:07 ET | 1370 | 18.72 |
11:12 ET | 800 | 18.66 |
11:14 ET | 720 | 18.665 |
11:16 ET | 700 | 18.71 |
11:18 ET | 200 | 18.7 |
11:21 ET | 278 | 18.66 |
11:23 ET | 200 | 18.6983 |
11:25 ET | 4003 | 18.735 |
11:30 ET | 11358 | 18.585 |
11:32 ET | 100 | 18.61 |
11:41 ET | 979 | 18.7 |
11:45 ET | 420 | 18.7036 |
11:50 ET | 1600 | 18.595 |
11:54 ET | 3576 | 18.46 |
11:56 ET | 200 | 18.4 |
11:57 ET | 282 | 18.35 |
11:59 ET | 260 | 18.2201 |
12:01 ET | 1000 | 18.3376 |
12:06 ET | 1000 | 18.33 |
12:08 ET | 600 | 18.3 |
12:12 ET | 300 | 18.35 |
12:14 ET | 1000 | 18.25 |
12:15 ET | 200 | 18.28 |
12:19 ET | 8041 | 18.23 |
12:24 ET | 2930 | 18.1201 |
12:28 ET | 300 | 18.11 |
12:30 ET | 100 | 18.15 |
12:33 ET | 100 | 18.1744 |
12:42 ET | 2310 | 18.14 |
12:44 ET | 100 | 18.095 |
12:51 ET | 1327 | 18.14 |
12:53 ET | 300 | 18.15 |
12:55 ET | 3200 | 18.24 |
12:57 ET | 100 | 18.27 |
01:00 ET | 541 | 18.275 |
01:02 ET | 103 | 18.275 |
01:04 ET | 601 | 18.2184 |
01:08 ET | 516 | 18.165 |
01:13 ET | 1152 | 18.15 |
01:15 ET | 600 | 18.1498 |
01:18 ET | 400 | 18.15 |
01:22 ET | 200 | 18.13 |
01:24 ET | 100 | 18.095 |
01:26 ET | 200 | 18.06 |
01:27 ET | 400 | 18.095 |
01:29 ET | 1300 | 18.04 |
01:31 ET | 1000 | 18.17 |
01:33 ET | 300 | 18.21 |
01:38 ET | 100 | 18.19 |
01:42 ET | 5682 | 18.275 |
01:45 ET | 300 | 18.27 |
01:49 ET | 840 | 18.355 |
01:51 ET | 200 | 18.33 |
01:54 ET | 100 | 18.315 |
01:58 ET | 302 | 18.32 |
02:02 ET | 800 | 18.2 |
02:03 ET | 100 | 18.225 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 228.7M | -3.1x | --- |
Kyverna Therapeutics Inc | 228.2M | 0.0x | --- |
XBiotech Inc | 230.0M | -6.3x | --- |
Nkarta Inc | 225.1M | -1.7x | --- |
Trevi Therapeutics Inc | 223.7M | -6.8x | --- |
Solid Biosciences Inc | 234.5M | -1.9x | --- |
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $228.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 12.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.60 |
EPS | $-5.82 |
Book Value | $-1.56 |
P/E Ratio | -3.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.